164 related articles for article (PubMed ID: 16377418)
1. Spinal cord planning risk volumes for intensity-modulated radiation therapy of head-and-neck cancer.
Breen SL; Craig T; Bayley A; O'Sullivan B; Kim J; Jaffray D
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):321-5. PubMed ID: 16377418
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
3. Adequate margins for random setup uncertainties in head-and-neck IMRT.
Astreinidou E; Bel A; Raaijmakers CP; Terhaard CH; Lagendijk JJ
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):938-44. PubMed ID: 15708278
[TBL] [Abstract][Full Text] [Related]
4. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.
Vanetti E; Clivio A; Nicolini G; Fogliata A; Ghosh-Laskar S; Agarwal JP; Upreti RR; Budrukkar A; Murthy V; Deshpande DD; Shrivastava SK; Dinshaw KA; Cozzi L
Radiother Oncol; 2009 Jul; 92(1):111-7. PubMed ID: 19157609
[TBL] [Abstract][Full Text] [Related]
5. Can intensity-modulated radiation therapy of the paraaortic region overcome the problems of critical organ tolerance?
Hermesse J; Devillers M; Deneufbourg JM; Nickers P
Strahlenther Onkol; 2005 Mar; 181(3):185-90. PubMed ID: 15756523
[TBL] [Abstract][Full Text] [Related]
6. Impact of patient setup error in the treatment of head and neck cancer with intensity modulated radiation therapy.
Prabhakar R; Laviraj MA; Haresh KP; Julka PK; Rath GK
Phys Med; 2010 Jan; 26(1):26-33. PubMed ID: 19576833
[TBL] [Abstract][Full Text] [Related]
7. Dose sparing of brainstem and spinal cord for re-irradiating recurrent head and neck cancer with intensity-modulated radiotherapy.
Chen CC; Lee CC; Mah D; Sharma R; Landau E; Garg M; Wu A
Med Dosim; 2011; 36(1):21-7. PubMed ID: 20202815
[TBL] [Abstract][Full Text] [Related]
8. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer?
Sanguineti G; Endres EJ; Gunn BG; Parker B
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):931-8. PubMed ID: 17011465
[TBL] [Abstract][Full Text] [Related]
9. Impact of the spinal cord position uncertainty on the dose received during head and neck helical tomotherapy.
Piotrowski T; Kaźmierska J; Sokołowski A; Skórska M; Jodda A; Ryczkowski A; Cholewiński W; Bąk B
J Med Imaging Radiat Oncol; 2013 Aug; 57(4):503-11. PubMed ID: 23870352
[TBL] [Abstract][Full Text] [Related]
10. Impact of geometric uncertainties on dose distribution during intensity modulated radiotherapy of head-and-neck cancer: the need for a planning target volume and a planning organ-at-risk volume.
Ballivy O; Parker W; Vuong T; Shenouda G; Patrocinio H
Curr Oncol; 2006 Jun; 13(3):108-15. PubMed ID: 17576450
[TBL] [Abstract][Full Text] [Related]
11. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck.
Webster GJ; Rowbottom CG; Ho KF; Slevin NJ; Mackay RI
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):617-22. PubMed ID: 18793966
[TBL] [Abstract][Full Text] [Related]
13. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer.
Krayenbuehl J; Davis JB; Ciernik IF
Radiother Oncol; 2006 Nov; 81(2):151-7. PubMed ID: 17055095
[TBL] [Abstract][Full Text] [Related]
14. Limitations of the planning organ at risk volume (PRV) concept.
Stroom JC; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):279-86. PubMed ID: 16904527
[TBL] [Abstract][Full Text] [Related]
15. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
[TBL] [Abstract][Full Text] [Related]
16. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.
Caudell JJ; Burnett OL; Schaner PE; Bonner JA; Duan J
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):462-7. PubMed ID: 19577862
[TBL] [Abstract][Full Text] [Related]
17. A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Poon I; Xia P; Weinberg V; Sultanem K; Akazawa C; Akazawa P; Verhey L; Quivey JM; Lee N
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1625-33. PubMed ID: 18035216
[TBL] [Abstract][Full Text] [Related]
18. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
19. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: a comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy.
Sheng K; Molloy JA; Read PW
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):917-23. PubMed ID: 16751074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
